Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
sunitinib
i
Other names:
PNU 290940, SU 011248, SU011248, PNU-290940, SU-11428, SU-011248, PNU-290940AD, PHA-290940AD, PHA-290940, Sutib
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(139)
News
Trials
Company:
Generic mfg.
Drug class:
c-KIT inhibitor, VEGFR inhibitor, PDGFR inhibitor
Related drugs:
‹
dasatinib (215)
imatinib (166)
lenvatinib (90)
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
GSK6042981 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
E7050 (1)
CDX-0158 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
axitinib (34)
fruquintinib (24)
cediranib (9)
TKI258 (9)
surufatinib (7)
MGCD265 (4)
E 3810 (4)
OMP-305B83 (3)
chiauranib (1)
DC101 (1)
vorolanib (1)
KD019 (1)
BMS690514 (0)
CVX-241 (0)
ESK981 (0)
adAptVEGF-C adenoviral vector (0)
SU 14813 (0)
SYHA1813 (0)
VEGFR1-1084 (0)
ABT-165 (0)
IMC-18F1 (0)
ABT348 (0)
PI-88 (0)
SU5416 (0)
GS 6624 (0)
RG7221 (0)
Max-40279 (2)
squalamine (0)
pegpleranib (0)
R1530 (0)
dasatinib (215)
imatinib (166)
lenvatinib (90)
YD312 (21)
ripretinib (11)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
GSK6042981 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
E7050 (1)
CDX-0158 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
axitinib (34)
fruquintinib (24)
cediranib (9)
TKI258 (9)
surufatinib (7)
MGCD265 (4)
E 3810 (4)
OMP-305B83 (3)
chiauranib (1)
DC101 (1)
vorolanib (1)
KD019 (1)
BMS690514 (0)
CVX-241 (0)
ESK981 (0)
adAptVEGF-C adenoviral vector (0)
SU 14813 (0)
SYHA1813 (0)
VEGFR1-1084 (0)
ABT-165 (0)
IMC-18F1 (0)
ABT348 (0)
PI-88 (0)
SU5416 (0)
GS 6624 (0)
RG7221 (0)
Max-40279 (2)
squalamine (0)
pegpleranib (0)
R1530 (0)
›
Associations
(139)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
KIT mutation
Thymic Carcinoma
KIT mutation
Thymic Carcinoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Meningioma
No biomarker
Meningioma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Chordoma
No biomarker
Chordoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Sarcoma
No biomarker
Sarcoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
No biomarker
Clear Cell Renal Cell Carcinoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Colorectal Cancer
No biomarker
Colorectal Cancer
sunitinib
Resistant: A2 - Guideline
sunitinib
Resistant
:
A2
sunitinib
Resistant: A2 - Guideline
sunitinib
Resistant
:
A2
No biomarker
Pancreatic Cancer
No biomarker
Pancreatic Cancer
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.